Fiera Capital Corp Has $728.54 Million Holdings in CME Group Inc. (NASDAQ:CME)

Key Points

• Fiera Capital Corp reduced its stake in CME Group by 16.9%, selling 559,593 shares, and now holds approximately 2.6% of its portfolio in CME Group, valuing at about $728.54 million.
• Other institutional investors showed significant activity, with Price T Rowe Associates Inc. increasing its stake by 89.9% and GAMMA Investing LLC boosting its holdings by 32,941.0%.
• Recent analyst ratings for CME Group include a "neutral" rating from UBS Group with a target price of $305.00 and a downgrade from JPMorgan Chase with a reduced target of $211.00.

Fiera Capital Corp lessened its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 16.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,746,215 shares of the financial services provider's stock after selling 559,593 shares during the period. CME Group comprises about 2.6% of Fiera Capital Corp's portfolio, making the stock its 8th biggest position. Fiera Capital Corp owned 0.76% of CME Group worth $728,543,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Heartland Bank & Trust Co purchased a new stake in shares of CME Group in the first quarter worth approximately $377,000. Catalyst Capital Advisors LLC grew its holdings in shares of CME Group by 256.9% in the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after acquiring an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. purchased a new stake in CME Group in the first quarter worth $367,000. Fulcrum Equity Management purchased a new stake in CME Group in the first quarter worth $258,000. Finally, Aspire Growth Partners LLC purchased a new stake in CME Group in the fourth quarter worth $548,000. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently commented on CME. UBS Group reaffirmed a "neutral" rating and issued a $305.00 price target on shares of CME Group in a report on Thursday, July 24th. Citigroup lifted their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research note on Thursday, July 3rd. Oppenheimer lifted their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Royal Bank Of Canada restated a "sector perform" rating and set a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Finally, Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, CME Group currently has an average rating of "Hold" and a consensus price target of $261.93.

Insider Transactions at CME Group

In other news, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the transaction, the director owned 5,400 shares of the company's stock, valued at $1,471,824. This represents a 35.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of the firm's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the transaction, the director owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. The trade was a 12.00% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,400 shares of company stock valued at $2,881,130. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Up 0.7%

CME stock traded up $1.97 during midday trading on Friday, hitting $280.25. The company's stock had a trading volume of 1,869,018 shares, compared to its average volume of 2,369,306. The company has a market cap of $100.99 billion, a PE ratio of 27.13, a P/E/G ratio of 4.93 and a beta of 0.44. CME Group Inc. has a 12 month low of $196.62 and a 12 month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm's 50-day moving average is $276.14 and its 200-day moving average is $263.55.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.56 EPS. On average, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's dividend payout ratio is 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.